TreeWAS – Variant ID: rs8103033

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E28 Ovarian dysfunction	0.026	0.974	0.000
E28.3 Primary ovarian failure	0.026	0.974	0.000
E34.8 Other specified endocrine disorders	0.025	0.975	0.000
E34 Other endocrine disorders	0.025	0.975	0.000
E20-E35 Disorders of other endocrine glands	0.024	0.976	0.000
E28.2 Polycystic ovarian syndrome	0.023	0.977	0.000
E24 Cushing's syndrome	0.022	0.978	0.000
E34.9 Endocrine disorder, unspecified	0.020	0.980	0.000
E34.3 Short stature, not elsewhere classified	0.020	0.980	0.000
E26 Hyperaldosteronism	0.019	0.981	0.000
E31 Polyglandular dysfunction	0.019	0.981	0.000
E28.9 Ovarian dysfunction, unspecified	0.019	0.981	0.000
E28.8 Other ovarian dysfunction	0.019	0.981	0.000
E28.1 Androgen excess	0.019	0.981	0.000
E28.0 Oestrogen excess	0.019	0.981	0.000
E24.9 Cushing's syndrome, unspecified	0.018	0.982	0.000
E22 Hyperfunction of pituitary gland	0.018	0.982	0.000
E34.5 Androgen resistance syndrome	0.018	0.982	0.000
E34.4 Constitutional tall stature	0.018	0.982	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.018	0.982	0.000
E34.1 Other hypersecretion of intestinal hormones	0.018	0.982	0.000
E34.0 Carcinoid syndrome	0.018	0.982	0.000
E29 Testicular dysfunction	0.018	0.982	0.000
E25 Adrenogenital disorders	0.018	0.982	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.018	0.982	0.000
E32 Diseases of thymus	0.018	0.982	0.000
E30 Disorders of puberty, not elsewhere classified	0.018	0.982	0.000
E24.0 Pituitary-dependent Cushing's disease	0.017	0.983	0.000
E20 Hypoparathyroidism	0.017	0.983	0.000
E24.2 Drug-induced Cushing's syndrome	0.017	0.983	0.000
E24.8 Other Cushing's syndrome	0.017	0.983	0.000
N03.9 Unspecified	0.017	0.983	0.000
E23 Hypofunction and other disorders of pituitary gland	0.016	0.984	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.016	0.984	0.000
E24.3 Ectopic ACTH syndrome	0.016	0.984	0.000
E24.1 Nelson's syndrome	0.016	0.984	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.016	0.984	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.016	0.984	0.000
T51.0 Ethanol	0.015	0.985	0.000
T43.2 Other and unspecified antidepressants	0.015	0.985	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.015	0.985	0.000
E27 Other disorders of adrenal gland	0.015	0.985	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.015	0.985	0.000
E31.0 Autoimmune polyglandular failure	0.015	0.985	0.000
E26.9 Hyperaldosteronism, unspecified	0.014	0.985	0.000
T42.4 Benzodiazepines	0.014	0.986	0.000
T36 Poisoning by systemic antibiotics	0.014	0.986	0.000
E26.0 Primary hyperaldosteronism	0.014	0.986	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.014	0.986	0.000
T42.1 Iminostilbenes	0.014	0.986	0.000
T42.0 Hydantoin derivatives	0.014	0.986	0.000
E26.8 Other hyperaldosteronism	0.014	0.986	0.000
E26.1 Secondary hyperaldosteronism	0.014	0.986	0.000
E31.9 Polyglandular dysfunction, unspecified	0.013	0.986	0.000
E31.8 Other polyglandular dysfunction	0.013	0.986	0.000
E31.1 Polyglandular hyperfunction	0.013	0.986	0.000
E29.1 Testicular hypofunction	0.014	0.986	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.014	0.986	0.000
E23.6 Other disorders of pituitary gland	0.013	0.986	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.013	0.987	0.000
E22.8 Other hyperfunction of pituitary gland	0.013	0.987	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.013	0.987	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.013	0.987	0.000
E29.9 Testicular dysfunction, unspecified	0.013	0.987	0.000
E29.8 Other testicular dysfunction	0.013	0.987	0.000
E29.0 Testicular hyperfunction	0.013	0.987	0.000
T42.3 Barbiturates	0.013	0.987	0.000
E25.9 Adrenogenital disorder, unspecified	0.013	0.987	0.000
E25.8 Other adrenogenital disorders	0.013	0.987	0.000
E23.7 Disorder of pituitary gland, unspecified	0.013	0.987	0.000
E30.9 Disorder of puberty, unspecified	0.013	0.987	0.000
E30.8 Other disorders of puberty	0.013	0.987	0.000
E30.1 Precocious puberty	0.013	0.987	0.000
E30.0 Delayed puberty	0.013	0.987	0.000
E32.9 Disease of thymus, unspecified	0.013	0.987	0.000
E32.8 Other diseases of thymus	0.013	0.987	0.000
E32.1 Abscess of thymus	0.013	0.987	0.000
E32.0 Persistent hyperplasia of thymus	0.013	0.987	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.013	0.987	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.013	0.987	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.013	0.987	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.013	0.987	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.013	0.987	0.000
E20.8 Other hypoparathyroidism	0.012	0.987	0.000
E20.1 Pseudohypoparathyroidism	0.012	0.987	0.000
E20.0 Idiopathic hypoparathyroidism	0.012	0.987	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.012	0.987	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.012	0.987	0.000
E22.1 Hyperprolactinaemia	0.012	0.988	0.000
E20.9 Hypoparathyroidism, unspecified	0.012	0.988	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.988	0.000
E22.0 Acromegaly and pituitary gigantism	0.012	0.988	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.012	0.988	0.000
E27.9 Disorder of adrenal gland, unspecified	0.012	0.988	0.000
T50.1 Loop [high-ceiling] diuretics	0.012	0.988	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.012	0.988	0.000
E23.1 Drug-induced hypopituitarism	0.012	0.988	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.012	0.988	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
T36.4 Tetracyclines	0.012	0.988	0.000
T36.0 Penicillins	0.012	0.988	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.011	0.989	0.000
T36.3 Macrolides	0.011	0.989	0.000
T50.8 Diagnostic agents	0.011	0.989	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.011	0.989	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.989	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
E27.5 Adrenomedullary hyperfunction	0.011	0.989	0.000
E27.0 Other adrenocortical overactivity	0.011	0.989	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.011	0.989	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.011	0.989	0.000
T43.9 Psychotropic drug, unspecified	0.011	0.989	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.011	0.989	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.011	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.011	0.989	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.011	0.989	0.000
T46.1 Calcium-channel blockers	0.011	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
I63 Cerebral infarction	0.011	0.989	0.000
E21.2 Other hyperparathyroidism	0.011	0.989	0.000
N03 Chronic nephritic syndrome	0.011	0.989	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.011	0.989	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.010	0.989	0.000
T36.9 Systemic antibiotic, unspecified	0.010	0.989	0.000
T36.8 Other systemic antibiotics	0.010	0.989	0.000
T36.7 Antifungal antibiotics, systemically used	0.010	0.989	0.000
T36.6 Rifamycins	0.010	0.989	0.000
T36.5 Aminoglycosides	0.010	0.989	0.000
T36.2 Chloramphenicol group	0.010	0.989	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.010	0.989	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.010	0.990	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.010	0.990	0.000
E27.8 Other specified disorders of adrenal gland	0.010	0.990	0.000
T50.7 Analeptics and opioid receptor antagonists	0.010	0.990	0.000
T50.5 Appetite depressants	0.010	0.990	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.010	0.990	0.000
T50.0 Mineralocorticoids and their antagonists	0.010	0.990	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.010	0.990	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.010	0.990	0.000
I63.8 Other cerebral infarction	0.010	0.990	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.990	0.000
E21.4 Other specified disorders of parathyroid gland	0.010	0.990	0.000
E23.2 Diabetes insipidus	0.010	0.990	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.010	0.990	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.009	0.990	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.009	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.009	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.009	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.009	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.009	0.990	0.000
T44.0 Anticholinesterase agents	0.009	0.990	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.009	0.990	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
T40.3 Methadone	0.009	0.991	0.000
I08.0 Disorders of both mitral and aortic valves	0.000	0.991	0.009
E27.1 Primary adrenocortical insufficiency	0.009	0.991	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.009	0.991	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.009	0.991	0.000
T46.7 Peripheral vasodilators	0.009	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.009	0.991	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
R14 Flatulence and related conditions	0.009	0.991	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.009	0.991	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.991	0.009
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.009	0.991	0.000
I08 Multiple valve diseases	0.000	0.991	0.009
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.009	0.991	0.000
T48.5 Anti-common-cold drugs	0.009	0.991	0.000
T48.4 Expectorants	0.009	0.991	0.000
T48.3 Antitussives	0.009	0.991	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.009	0.991	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.009	0.991	0.000
T48.0 Oxytocic drugs	0.009	0.991	0.000
E27.2 Addisonian crisis	0.009	0.991	0.000
N03.1 Focal and segmental glomerular lesions	0.009	0.991	0.000
T40.1 Heroin	0.009	0.991	0.000
T40.5 Cocaine	0.008	0.991	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.009	0.991	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.008	0.992	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.008	0.992	0.000
T40.8 Lysergide [LSD]	0.008	0.992	0.000
T40.7 Cannabis (derivatives)	0.008	0.992	0.000
T40.0 Opium	0.008	0.992	0.000
T40.4 Other synthetic narcotics	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
T40.6 Other and unspecified narcotics	0.008	0.992	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.008	0.992	0.000
T39.1 4-Aminophenol derivatives	0.008	0.992	0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.008	0.992	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.008	0.992	0.000
T47.4 Other laxatives	0.008	0.992	0.000
N03.8 Other	0.008	0.992	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.008	0.992	0.000
N03.6 Dense deposit disease	0.008	0.992	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.008	0.992	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.008	0.992	0.000
N03.2 Diffuse membranous glomerulonephritis	0.008	0.992	0.000
N03.0 Minor glomerular abnormality	0.008	0.992	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.992	0.000
I08.9 Multiple valve disease, unspecified	0.000	0.992	0.008
T46.5 Other antihypertensive drugs, not elsewhere classified	0.007	0.992	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.992	0.000
T47.7 Emetics	0.007	0.992	0.000
T47.6 Antidiarrhoeal drugs	0.007	0.992	0.000
T47.5 Digestants	0.007	0.992	0.000
T47.3 Saline and osmotic laxatives	0.007	0.992	0.000
T47.2 Stimulant laxatives	0.007	0.992	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.008	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.992	0.000
T37.5 Antiviral drugs	0.007	0.992	0.000
T37.4 Anthelminthics	0.007	0.992	0.000
T37.3 Other antiprotozoal drugs	0.007	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.992	0.000
T37.1 Antimycobacterial drugs	0.007	0.992	0.000
T37.0 Sulphonamides	0.007	0.992	0.000
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993	0.000
T39.2 Pyrazolone derivatives	0.007	0.993	0.000
I08.8 Other multiple valve diseases	0.000	0.993	0.007
N88.2 Stricture and stenosis of cervix uteri	0.007	0.993	0.000
I05-I09 Chronic rheumatic heart diseases	0.000	0.993	0.007
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.007	0.993	0.000
I05.9 Mitral valve disease, unspecified	0.000	0.993	0.007
T38.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.007	0.993	0.000
T38.7 Androgens and anabolic congeners	0.007	0.993	0.000
T38.5 Other oestrogens and progestogens	0.007	0.993	0.000
T38.4 Oral contraceptives	0.007	0.993	0.000
T38.2 Antithyroid drugs	0.007	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.007	0.993	0.000
E21.0 Primary hyperparathyroidism	0.007	0.993	0.000
T45.5 Anticoagulants	0.007	0.993	0.000
E23.0 Hypopituitarism	0.007	0.993	0.000
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.007	0.993	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.007	0.993	0.000
I05 Rheumatic mitral valve diseases	0.000	0.993	0.007
I08.2 Disorders of both aortic and tricuspid valves	0.000	0.993	0.007
I07 Rheumatic tricuspid valve diseases	0.000	0.993	0.007
T39.0 Salicylates	0.007	0.993	0.000
T51 Toxic effect of alcohol	0.007	0.993	0.000
T40.2 Other opioids	0.007	0.993	0.000
S66 Injury of muscle and tendon at wrist and hand level	0.007	0.993	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.993	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.006	0.993	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.006	0.993	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.006	0.994	0.000
T45.8 Other primarily systemic and haematological agents	0.006	0.994	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.006	0.994	0.000
T45.6 Fibrinolysis-affecting drugs	0.006	0.994	0.000
T45.4 Iron and its compounds	0.006	0.994	0.000
T45.3 Enzymes, not elsewhere classified	0.006	0.994	0.000
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
I07.1 Tricuspid insufficiency	0.000	0.994	0.006
T45.2 Vitamins, not elsewhere classified	0.006	0.994	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.006	0.994	0.000
I05.2 Mitral stenosis with insufficiency	0.000	0.994	0.006
T38.1 Thyroid hormones and substitutes	0.006	0.994	0.000
E21.3 Hyperparathyroidism, unspecified	0.006	0.994	0.000
N87.0 Mild cervical dysplasia	0.000	0.994	0.006
I09 Other rheumatic heart diseases	0.000	0.994	0.006
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.006	0.994	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.994	0.000
S66.8 Injury of other muscles and tendons at wrist and hand level	0.005	0.995	0.000
A08.4 Viral intestinal infection, unspecified	0.000	0.995	0.005
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level	0.005	0.995	0.000
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.005	0.995	0.000
I06 Rheumatic aortic valve diseases	0.000	0.995	0.005
I05.8 Other mitral valve diseases	0.000	0.995	0.005
I07.9 Tricuspid valve disease, unspecified	0.000	0.995	0.005
I07.8 Other tricuspid valve diseases	0.000	0.995	0.005
I07.2 Tricuspid stenosis with insufficiency	0.000	0.995	0.005
I07.0 Tricuspid stenosis	0.000	0.995	0.005
T51.8 Other alcohols	0.005	0.995	0.000
T51.3 Fusel oil	0.005	0.995	0.000
T51.2 2-Propanol	0.005	0.995	0.000
T51.1 Methanol	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
I05.0 Mitral stenosis	0.000	0.995	0.005
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.005	0.995	0.000
I09.9 Rheumatic heart disease, unspecified	0.000	0.995	0.005
F22.0 Delusional disorder	0.005	0.995	0.000
G44.2 Tension-type headache	0.004	0.996	0.000
I09.8 Other specified rheumatic heart diseases	0.000	0.996	0.004
I09.2 Chronic rheumatic pericarditis	0.000	0.996	0.004
I09.1 Rheumatic diseases of endocardium, valve unspecified	0.000	0.996	0.004
I09.0 Rheumatic myocarditis	0.000	0.996	0.004
Y84.2 Radiological procedure and radiotherapy	0.000	0.996	0.004
E55.9 Vitamin D deficiency, unspecified	0.004	0.996	0.000
I06.1 Rheumatic aortic insufficiency	0.000	0.996	0.004
N00-N08 Glomerular diseases	0.004	0.996	0.000
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.004	0.996	0.000
T51.9 Alcohol, unspecified	0.004	0.996	0.000
I06.9 Rheumatic aortic valve disease, unspecified	0.000	0.996	0.004
I06.8 Other rheumatic aortic valve diseases	0.000	0.996	0.004
I06.2 Rheumatic aortic stenosis with insufficiency	0.000	0.996	0.004
K59.8 Other specified functional intestinal disorders	0.004	0.996	0.000
I77.1 Stricture of artery	0.000	0.996	0.004
X62.9 Unspecified place	0.004	0.996	0.000
Y40.8 Other systemic antibiotics	0.000	0.996	0.004
N05 Unspecified nephritic syndrome	0.004	0.996	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.003	0.996	0.000
I06.0 Rheumatic aortic stenosis	0.000	0.997	0.003
N05.9 Unspecified	0.003	0.997	0.000
N87 Dysplasia of cervix uteri	0.000	0.997	0.003
N30.8 Other cystitis	0.000	0.997	0.003
N04 Nephrotic syndrome	0.003	0.997	0.000
X62.8 Other specified place	0.003	0.997	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.000	0.997	0.003
N07 Hereditary nephropathy, not elsewhere classified	0.003	0.997	0.000
N06 Isolated proteinuria with specified morphological lesion	0.003	0.997	0.000
N01 Rapidly progressive nephritic syndrome	0.003	0.997	0.000
N00 Acute nephritic syndrome	0.003	0.997	0.000
B08.1 Molluscum contagiosum	0.003	0.997	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N04.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.000	0.997	0.003
X60.8 Other specified place	0.003	0.997	0.000
I05.1 Rheumatic mitral insufficiency	0.001	0.997	0.002
N88 Other noninflammatory disorders of cervix uteri	0.003	0.997	0.000
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
D11.0 Parotid gland	0.000	0.997	0.003
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.997	0.003
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.000	0.997	0.003
I44.0 Atrioventricular block, first degree	0.003	0.997	0.000
N04.0 Minor glomerular abnormality	0.003	0.997	0.000
N05.6 Dense deposit disease	0.003	0.997	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N05.0 Minor glomerular abnormality	0.003	0.997	0.000
X60-X84 Intentional self-harm	0.003	0.997	0.000
X62.0 Home	0.003	0.997	0.000
X62.7 Farm	0.003	0.997	0.000
X62.6 Industrial and construction area	0.003	0.997	0.000
X62.5 Trade and service area	0.003	0.997	0.000
X62.4 Street and highway	0.003	0.997	0.000
X62.3 Sports and athletics area	0.003	0.997	0.000
X62.2 School, other institution and public administrative area	0.003	0.997	0.000
X62.1 Residential institution	0.003	0.997	0.000
A49.0 Staphylococcal infection, unspecified	0.000	0.997	0.003
N08 Glomerular disorders in diseases classified elsewhere	0.003	0.997	0.000
X65.8 Other specified place	0.003	0.997	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.003	0.997	0.000
N04.8 Other	0.003	0.997	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N04.6 Dense deposit disease	0.003	0.997	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.003	0.997	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.997	0.003
N05.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N04.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
G57.8 Other mononeuropathies of lower limb	0.000	0.997	0.003
N00.9 Unspecified	0.002	0.997	0.000
N00.8 Other	0.002	0.997	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N00.6 Dense deposit disease	0.002	0.997	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N00.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N00.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N00.0 Minor glomerular abnormality	0.002	0.997	0.000
N01.9 Unspecified	0.002	0.997	0.000
N01.8 Other	0.002	0.997	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N01.6 Dense deposit disease	0.002	0.997	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N01.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N01.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N01.0 Minor glomerular abnormality	0.002	0.997	0.000
N06.9 Unspecified	0.002	0.997	0.000
N06.8 Other	0.002	0.997	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N06.6 Dense deposit disease	0.002	0.997	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N06.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N06.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N06.0 Minor glomerular abnormality	0.002	0.997	0.000
N07.9 Unspecified	0.002	0.997	0.000
N07.8 Other	0.002	0.997	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N07.6 Dense deposit disease	0.002	0.997	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N07.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N07.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N07.0 Minor glomerular abnormality	0.002	0.997	0.000
N88.3 Incompetence of cervix uteri	0.002	0.997	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
F22 Persistent delusional disorders	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
N88.4 Hypertrophic elongation of cervix uteri	0.002	0.998	0.000
N88.0 Leukoplakia of cervix uteri	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
E55 Vitamin D deficiency	0.002	0.998	0.000
N05.8 Other	0.002	0.998	0.000
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000
X60.6 Industrial and construction area	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X60.4 Street and highway	0.002	0.998	0.000
X60.3 Sports and athletics area	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.002	0.998	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.998	0.002
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
N04.9 Unspecified	0.002	0.998	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.002	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.002	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
X65.9 Unspecified place	0.002	0.998	0.000
X65.0 Home	0.002	0.998	0.000
X65.7 Farm	0.002	0.998	0.000
X65.6 Industrial and construction area	0.002	0.998	0.000
X65.5 Trade and service area	0.002	0.998	0.000
X65.4 Street and highway	0.002	0.998	0.000
X65.3 Sports and athletics area	0.002	0.998	0.000
X65.2 School, other institution and public administrative area	0.002	0.998	0.000
X65.1 Residential institution	0.002	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.998	0.002
T18.1 Foreign body in oesophagus	0.000	0.998	0.002
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.002	0.998	0.000
S90.8 Other superficial injuries of ankle and foot	0.002	0.998	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.002	0.998	0.000
T55 Toxic effect of soaps and detergents	0.002	0.998	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.002	0.998	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.002	0.998	0.000
X68.9 Unspecified place	0.002	0.998	0.000
N02 Recurrent and persistent haematuria	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.002	0.998	0.000
T54 Toxic effect of corrosive substances	0.002	0.998	0.000
M19.96 Arthrosis, unspecified-Lower leg	0.000	0.998	0.002
N87.1 Moderate cervical dysplasia	0.000	0.998	0.002
X61.4 Street and highway	0.002	0.998	0.000
C32.9 Larynx, unspecified	0.000	0.998	0.002
G44 Other headache syndromes	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
F22.9 Persistent delusional disorder, unspecified	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations